CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ALLTOX project introduces MYA, a cost-effective allergy screening test that allows individuals to identify their allergy triggers quickly. By providing accessible testing through pharmacies, it aims to improve diagnosis rates and management of allergies, enhancing patients' quality of life.
Allergies are chronic conditions caused by an extreme immune response to inhalant and food allergens that affect today 500 million (M) individuals worldwide and 150 M in Europe.
International institutions all agree in the benefits that early allergy diagnosis and targeted treatment could bring to society.
However, only 5% of the population gets a proper diagnosis, either due to limited awareness or scarcity of allergy specialists.
Thus, patients try to self-manage their condition and non-special…
ALLTOX S.R.L.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
